Shandong Weigao Group Medical Polymer Co. has agreed to buy closely held Argon Medical Devices Inc. for $850 million, co...
Merck, a leading science and technology company, announced the opening of its first BioReliance End-to-End Biodevelopmen...
WuXi NextCODE, a global platform for genomic data, has successfully raised $240 million in Series B financing. The compa...
After the long wait, Chinese firm Fosun pharma has decided to settle with 74 percent stake of India’s Glan...
German industrial group Siemens AG has entered into a partnership with Tsinghua University, one of Siemens' center of kn...
Eight Roads Ventures, the proprietary investment arm of Fidelity International Ltd, has launched its first dedicated Chi...
Magnetic nanoparticle clusters have the power to punch through biofilms to reach bacteria that can foul water treatment ...
Columbia China, a 50-50 joint venture between Seattle’s Columbia Pacific Management and Singapore investment compa...
In a bid to bring operational efficiency and improve data management, Chinese healthcare group Fosun Pharma has ad...
Cambricon, an artificial intelligence (AI) chipmaker based in China, has raised $100 million in series A funding led by ...
Swedish drug giant Medivir recently announced that it has offloaded its exclusive rights to develop, manufacture and com...
Visiting Chinese Vice-Premier, Wang Yang, on Wednesday pledged full support to Nepal for the development and promotion o...
Ankon Technologies Co., Ltd., a U.S. and China-based company developing medical equipment for gastric diagnosis, has rai...
To cater to the increasing demand for exclusive health care services among the Chinese high net-worth, Vista, a veteran ...
Chinese pharma giant Shanghai pharma has inked a deal with contract logistics firm DHL Supply Chain to prepare its logis...
According to reports, GSK China has planned to pull down shutters on its neuroscience R&D center located in Shanghai...
WuXi AppTec, the leading global pharmaceutical and biopharmaceutical open access capability platform has ...
Dedicated to developing global antibody and recombinant protein bio-therapeutics, Hangzhou Just Biotherapeutics, Ltd. (J...